Coppersmith Capital Management
Activist investor battles on over ConMed as shareholders vote approaches
Embattled ConMed surges on reports of potential sale
K2M Group Holdings looks to raise $100M in IPO | Medtech Wall Street stories for the week of Mar. 17, 2014
ConMed delays annual meeting amid proxy war
Medtech personnel moves for the week of Mar. 10, 2014
ConMed proxy war gets ugly
February 28, 2014 by Brad Perriello
The proxy war over control of the board at ConMed turned ugly this week after serious allegations surfaced against 1 of the medical device company’s nominees for director.
